Showing results (1021-1030 of 1,137) with videos related to

Sort By:
Pageof 114
International Journal of Cardiology|May 16, 2020
Mon2-monocytes and increased CD-11b expression before transcatheter aortic valve implantation are associated with earlier deathC Pfluecke, S Wydra, K Berndt, et al.
Plos One|July 2, 2016
Identification of Shell Colour Pigments in Marine Snails Clanculus pharaonius and C. margaritarius (Trochoidea; Gastropoda)S T Williams, S Ito, K Wakamatsu, et al.
The Journal of Clinical Endocrinology and Metabolism|September 9, 2010
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelinePhyllis W Speiser, Ricardo Azziz, Laurence S Baskin, et al.
Cancer Research|April 17, 2004
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional toleranceAlfred Zippelius, Pascal Batard, Verena Rubio-Godoy, et al.
BMC Cancer|April 5, 2013
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortiumDietmar Pils, Dan Tong, Gudrun Hager, et al.
Frontiers in Urology|November 3, 2023
Decisional Support Needed when Facing Tough Decisions: Survey of Parents with Children having Differences of Sex DevelopmentMelissa Gardner, William B Brinkman, Meg Carley, et al.
International Journal of Pediatric Endocrinology|October 29, 2010
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase DeficiencyPhyllis W Speiser, Ricardo Azziz, Laurence S Baskin, et al.
Cardiovascular Radiation Medicine|March 29, 2001
The American Brachytherapy Society perspective on intravascular brachytherapyS Nag, P E Cole, I Crocker, et al.
Nature Immunology|January 22, 2019
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycleWan-Chen Cheng, Yao-Chen Tsui, Simone Ragusa, et al.
Journal of Translational Medicine|January 9, 2013
T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion proteinJulien Laurent, Cedric Touvrey, Silke Gillessen, et al.
Pageof 114